Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0352
-0.0055 (-13.51%)
At close: Oct 29, 2026

Emmaus Life Sciences Revenue

Emmaus Life Sciences had revenue of $6.32M in the quarter ending June 30, 2026, with 124.28% growth. This brings the company's total for the last twelve months to $15.53M, up 10.98% year-over-year. In the year 2025, Emmaus Life Sciences had annual revenue of $12.45M, down -25.22%. That makes Emmaus Life Sciences the 35,211th largest company in the world by revenue and 4,640th in the United States.

Revenue (ttm)
15.53M
Revenue Growth
+10.98%
P/S Ratio
0.16
Revenue / Employee
470.61K
Employees
33
Market Cap
2.47M

Revenue Chart

Revenue by Geography

  • United States 9.05M 72.7%
  • International 3.18M 25.5%
  • Other 225.00K 1.8%
Fiscal year ended Dec 31, 2025 See the full Emmaus Life Sciences breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.45M-4.20M-25.22%
Dec 31, 202416.65M-12.94M-43.73%
Dec 31, 202329.60M11.21M60.94%
Dec 31, 202218.39M-2.22M-10.77%
Dec 31, 202120.61M-2.56M-11.04%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CASI Pharmaceuticals20.11M
BioAtla8.50M
Vaccinex601.00K
GPL Holdings376.54K
Enzolytics46.59K
Revenue Rankings